- 期刊
從實證醫學討論Ursodeoxycholic Acid使用於慢性肝病之爭議
The Disputes on Ursodeoxycholic Acid for Chronic Liver Diseases: Evidence-Based Analysis
延伸閱讀
- 高嘉宏、陳定信（1995）。慢性肝炎之新分類：強調病因、發炎活性分級和纖維化分期之觀念。當代醫學，(261)，529-534。https://doi.org/10.29941/MT.199507.0002
- 衛生署全民健康保險爭議審議委員會（2005）。肝炎病患使用肝庇護劑之爭議。台灣醫學，9(2)，232-234。https://doi.org/10.6320/FJM.2005.9(2).13
- Chen, M. Y. (2013). B型肝炎患者中Statins藥物使用和急性肝炎住院風險之探討 [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2013.03055
- 賴世偉、廖光福、黃金財（2005）。Analysis of Nonalcoholic Fatty Liver in Patients Receiving Health Checkups: A Hospital-Based Study。輔仁醫學期刊，3(2)，75-80。https://www.airitilibrary.com/Article/Detail?DocID=18102093-200506-3-2-75-80-a
- Sugita, T., Amano, K., Nakano, M., NorikoMasubuchi, Sugihara, M., & Matsuura, T. (2015). Analysis of the Serum Bile Acid Composition for Differential Diagnosis in Patients with Liver Disease. Gastroenterology Research and Practice, 2015(), 365-374-154. https://doi.org/10.1155/2015/717431